ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
3.360
-0.070 (-2.04%)
At close: Mar 6, 2026, 4:00 PM EST
3.340
-0.020 (-0.60%)
After-hours: Mar 6, 2026, 7:13 PM EST
ENDRA Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 4 | 3 | 18 | 13 | 29 | 25 | |
| Market Cap Growth | 60.43% | -81.25% | 39.49% | -55.93% | 15.68% | 100.27% | |
| Enterprise Value | 4 | -1 | 15 | 6 | 18 | 22 | |
| Last Close Price | 3.36 | 6.26 | 3710.00 | 7122.51 | 24213.02 | 26250.03 | |
| PB Ratio | 15.43 | 1.31 | 3.17 | 1.78 | 2.70 | 3.52 | |
| P/TBV Ratio | 22.87 | 1.31 | 3.17 | 1.78 | 2.70 | 3.52 | |
| Debt / Equity Ratio | 3.07 | 0.30 | 0.10 | 0.10 | 0.07 | 0.11 | |
| Net Debt / Equity Ratio | -1.57 | -0.97 | -0.40 | -0.58 | -0.80 | -0.90 | |
| Net Debt / EBITDA Ratio | 0.03 | 0.23 | 0.22 | 0.32 | 0.76 | 0.57 | |
| Net Debt / FCF Ratio | 0.05 | 0.33 | 0.24 | 0.32 | 0.78 | 0.60 | |
| Quick Ratio | 0.99 | 5.34 | 3.14 | 2.87 | 6.13 | 7.33 | |
| Current Ratio | 1.31 | 5.67 | 3.36 | 3.16 | 7.83 | 8.32 | |
| Return on Equity (ROE) | -236.34% | -280.02% | -156.42% | -146.53% | -125.11% | -196.57% | |
| Return on Assets (ROA) | -101.97% | -120.66% | -82.05% | -74.26% | -66.42% | -90.19% | |
| Return on Capital Employed (ROCE) | -725.00% | -281.20% | -179.80% | -173.80% | -101.50% | -147.90% | |
| Earnings Yield | -204.30% | -342.39% | -56.13% | -102.57% | -38.53% | -46.53% | |
| FCF Yield | -130.22% | -220.66% | -53.47% | -100.96% | -38.31% | -42.94% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.